ArticleFrontiers in endocrinology2025

SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice.

Lanzexin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.